遺伝子検査が心臓突然死のリスクを予測(Genetic testing trifecta predicts risk of sudden cardiac death and arrhythmia)

ad

2025-11-11 ノースウェスタン大学

ノースウェスタン大学医学部の研究チームは、突然死や不整脈のリスクを高精度に予測する「三位一体型遺伝子リスクスコア」を開発した。これは、従来別々に行われていた①単一遺伝子変異(モノジェニック)解析、②多数の共通変異(ポリジェニック)解析、③全ゲノム解析を統合し、個人の心疾患リスクを360度評価する新手法である。523人の不整脈患者と596人の対照群を比較し、従来より高精度にリスク層別化が可能であることを実証した。研究は『Cell Reports Medicine』に掲載され、将来的にがんやパーキンソン病など他疾患への応用も期待される。

<関連情報>

ゲノム不整脈傾向スコアの組み合わせは累積リスクを描写する A combined genomic arrhythmia propensity score delineates cumulative risk

Tanner O. Monroe ∙ Megan J. Puckelwartz, ∙ Lorenzo L. Pesce, ∙ … ∙ Alfred L. George, Jr. ∙ Gregory Webster ∙ Elizabeth M. McNally
Cell Reports Medicine  Published:November 11, 2025
DOI:https://doi.org/10.1016/j.xcrm.2025.102455

Graphical abstract

遺伝子検査が心臓突然死のリスクを予測(Genetic testing trifecta predicts risk of sudden cardiac death and arrhythmia)

Highlights

  • Ventricular arrhythmias are often unpredictable and are influenced by genetic risk
  • Combining common, rare coding region and noncoding variation stratifies arrhythmia risk
  • The cumulative risk, called GAPS, performs with or without primary pathogenic mutations
  • This approach should be applicable to heritable complex disease

Summary

Cardiac ventricular arrhythmias can cause sudden death. Despite known genomic contributions, multigenic risk predictors are limited. The genetics of arrhythmias and cardiomyopathies overlap, with additional overlap with epilepsy. To improve genetic risk prediction, we assemble a cohort with non-ischemic ventricular arrhythmias and controls lacking cardiac diagnoses. Here, we integrate 18 polygenic scores; variants from clinical gene panels for coding regions of cardiomyopathy, arrhythmia, and epilepsy genes; and noncoding regulatory regions mapping to those genes. Polygenic scores alone hold prognostic value. Rare coding variants identify cumulative risk extending beyond known pathogenic/likely pathogenic variants. We also find enrichment of ultrarare regulatory variation. A risk predictor that combines all variant classes outperforms any single class or subset and replicates in a validation cohort. This combined genomic arrhythmia propensity score (GAPS) identifies high-risk individuals even among those who lack known primary pathogenic variants. This integrated approach serves as a model for other complex traits.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました